CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$0.20
+0.00 (+0.70%)
Open$0.20
Previous Close$0.20
Day High$0.20
Day Low$0.20
52W High$3.62
52W Low$0.19
Volume—
Avg Volume1.95M
Market Cap17.78M
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+11,640.2% upside
Current
$0.20
$0.20
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.12M | 24.12M | 28.34M |
| Net Income | 5.84M | 5.30M | 5.57M |
| Profit Margin | 21.6% | 22.0% | 19.7% |
| EBITDA | 7.13M | 6.78M | 8.30M |
| Free Cash Flow | 3.88M | 4.04M | 6.28M |
| Rev Growth | -4.2% | +22.6% | +13.0% |
| Debt/Equity | 1.37 | 0.99 | 1.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,422.11 | +0.72% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.96 | -0.05% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.82 | -1.30% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.25 | +0.07% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.20 | +0.10% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $81.95 | -0.45% | 12.8 | 33.59B |